Identification of a new in vivo phosphorylation site in the cytoplasmic carboxyl terminus of EBV-LMP1 by tandem mass spectrometry

Biochemical and Biophysical Research Communications

Volumn 348, Issue 1, 2006, Pages 47-55

  Chien, Kun Yi ^a   Chang, Yu Sun ^a   Yu, Jau Song ^a   Fan, Lin Wen ^b   Lee, Chien Wei ^a   Chi, Lang Ming ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Latent membrane protein 1; Mass spectrometry; Phosphorylation

Indexed keywords

AMINO ACID; GLUTATHIONE TRANSFERASE; LATENT MEMBRANE PROTEIN 1;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CELL LINE; CHEMICAL MODIFICATION; EMBRYO; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TANDEM MASS SPECTROMETRY;

AMINO ACID SEQUENCE; CATALYSIS; CELL LINE; GLUTATHIONE TRANSFERASE; HERPESVIRUS 4, HUMAN; HUMANS; MASS SPECTROMETRY; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; RECOMBINANT FUSION PROTEINS; VIRAL MATRIX PROTEINS;

HUMAN HERPESVIRUS 4;

EID: 33746793620     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.06.188     Document Type: Article

References (41)

1. Dirmeier U., Hoffmann R., Kilger E., Schultheiss U., Briseno C., Gires O., Kieser A., Eick D., Sugden B., and Hammerschmidt W. Latent membrane protein 1 of Epstein-Barr virus coordinately regulates proliferation with control of apoptosis. Oncogene 24 (2005) 1711-1717
2. Najjar I., Baran-Marszak F., Le C.C., Laguillier C., Schischmanoff O., Youlyouz-Marfak I., Schlee M., Bornkamm G.W., Raphael M., Feuillard J., and Fagard R. Latent membrane protein 1 regulates STAT1 through NF-kappaB-dependent interferon secretion in Epstein-Barr virus-immortalized B cells. J. Virol. 79 (2005) 4936-4943
3. Burgos J.S. Involvement of the Epstein-Barr virus in the nasopharyngeal carcinoma pathogenesis. Med. Oncol. 22 (2005) 113-121
4. Coffin III W.F., Geiger T.R., and Martin J.M. Transmembrane domains 1 and 2 of the latent membrane protein 1 of Epstein-Barr virus contain a lipid raft targeting signal and play a critical role in cytostasis. J. Virol. 77 (2003) 3749-3758
5. Lam N., and Sugden B. LMP1, a viral relative of the TNF receptor family, signals principally from intracellular compartments. EMBO J. 22 (2003) 3027-3038
6. Kaykas A., Worringer K., and Sugden B. LMP-1's transmembrane domains encode multiple functions required for LMP-1's efficient signaling. J. Virol. 76 (2002) 11551-11560
7. Moorthy R.K., and Thorley-Lawson D.A. Biochemical, genetic, and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J. Virol. 67 (1993) 2637-2645
8. Garcia B.A., Shabanowitz J., and Hunt D.F. Analysis of protein phosphorylation by mass spectrometry. Methods 35 (2005) 256-264
9. Mann M., Ong S.E., Gronborg M., Steen H., Jensen O.N., and Pandey A. Analysis of protein phosphorylation using mass spectrometry: deciphering the phosphoproteome. Trends Biotechnol. 20 (2002) 261-268
10. Zhou H., Watts J.D., and Aebersold R. A systematic approach to the analysis of protein phosphorylation. Nat. Biotechnol. 19 (2001) 375-378
11. Oda Y., Nagasu T., and Chait B.T. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19 (2001) 379-382
12. Peters E.C., Brock A., and Ficarro S.B. Exploring the phosphoproteome with mass spectrometry. Mini Rev. Med. Chem. 4 (2004) 313-324
13. Meggio F., and Pinna L.A. One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 17 (2003) 349-368
14. Imam-Sghiouar N., Joubert-Caron R., and Caron M. Application of metal-chelate affinity chromatography to the study of the phosphoproteome. Amino Acids 28 (2005) 105-109
15. Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.M., Polakiewicz R.D., and Comb M.J. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23 (2005) 94-101
16. Oda Y., Nagasu T., and Chait B.T. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19 (2001) 379-382
17. Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J., Lauffenburger D.A., and White F.M. Time-resolved mass spectrometry of tyrosine phosphorylatiopn sites in the EGF receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics (2005)
18. Boeri E.E., Bergatto E., Cabodi S., Silengo L., Tarone G., Defilippi P., and Jensen O.N. Systematic analysis of the epidermal growth factor receptor by mass spectrometry reveals stimulation-dependent multisite phosphorylation. Mol. Cell. Proteomics 4 (2005) 1107-1121
19. Ahn Y.H., Park E.J., Cho K., Kim J.Y., Ha S.H., Ryu S.H., and Yoo J.S. Dynamic identification of phosphopeptides using immobilized metal ion affinity chromatography enrichment, subsequent partial beta-elimination/chemical tagging and matrix-assisted laser desorption/ionization mass spectrometric analysis. Rapid Commun. Mass Spectrom. 18 (2004) 2495-2501
20. Pandey A., Andersen J.S., and Mann M. Use of mass spectrometry to study signaling pathways. Sci. STKE 2000 (2000) L1
21. Wang X., Goshe M.B., Soderblom E.J., Phinney B.S., Kuchar J.A., Li J., Asami T., Yoshida S., Huber S.C., and Clouse S.D. Identification and functional analysis of in vivo phosphorylation sites of the arabidopsis BRASSINOSTEROID-INSENSITIVE1 receptor kinase. Plant Cell (2005)
22. Sun X., Chiu J.F., and He Q.Y. Application of immobilized metal affinity chromatography in proteomics. Expert Rev. Proteomics 2 (2005) 649-657
23. Seeley E.H., Riggs L.D., and Regnier F.E. Reduction of non-specific binding in Ga(III) immobilized metal affinity chromatography for phosphopeptides by using endoproteinase glu-C as the digestive enzyme. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 817 (2005) 81-88
24. Gaberc-Porekar V., and Menart V. Perspectives of immobilized-metal affinity chromatography. J. Biochem. Biophys. Methods 49 (2001) 335-360
25. Chi L.M., Yu J.S., and Chang Y.S. Identification of protein kinase CK2 as a potent kinase of Epstein-Barr virus latent membrane protein 1. Biochem. Biophys. Res. Commun. 294 (2002) 586-591
26. Knight Z.A., Schilling B., Row R.H., Kenski D.M., Gibson B.W., and Shokat K.M. Phosphospecific proteolysis for mapping sites of protein phosphorylation. Nat. Biotechnol. 21 (2003) 1047-1054
27. Tang W., Pavlish O.A., Spiegelman V.S., Parkhitko A.A., and Fuchs S.Y. Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation. J. Biol. Chem. 278 (2003) 48942-48949
28. Rothenberger S., Burns K., Rousseaux M., Tschopp J., and Bron C. Ubiquitination of the Epstein-Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site. Oncogene 22 (2003) 5614-5618
29. Aviel S., Winberg G., Massucci M., and Ciechanover A. Degradation of the epstein-barr virus latent membrane protein 1 (LMP1) by the ubiquitin-proteasome pathway. Targeting via ubiquitination of the N-terminal residue. J. Biol. Chem. 275 (2000) 23491-23499
30. Zhang G., Spellman D.S., Skolnik E.Y., and Neubert T.A. Quantitative phosphotyrosine proteomics of EphB2 signaling by stable isotope labeling with amino acids in cell culture (SILAC). J. Proteome Res. 5 (2006) 581-588
31. Amanchy R., Kalume D.E., and Pandey A. Stable isotope labeling with amino acids in cell culture (SILAC) for studying dynamics of protein abundance and posttranslational modifications. Sci. STKE 2005 (2005) l2
32. Liebowitz D., Kopan R., Fuchs E., Sample J., and Kieff E. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol. Cell. Biol. 7 (1987) 2299-2308
33. Meggio F., and Pinna L.A. One-thousand-and-one substrates of protein kinase CK2?. FASEB J. 17 (2003) 349-368
34. Meggio F., Marin O., Boschetti M., Sarno S., and Pinna L.A. HIV-1 Rev transactivator: a beta-subunit directed substrate and effector of protein kinase CK2. Mol. Cell. Biochem. 227 (2001) 145-151
35. El-Guindy A.S., and Miller G. Phosphorylation of Epstein-Barr virus ZEBRA protein at its casein kinase 2 sites mediates its ability to repress activation of a viral lytic cycle late gene by Rta. J. Virol. 78 (2004) 7634-7644
36. Pinna L.A. The raison d'etre of constitutively active protein kinases: the lesson of CK2. Acc. Chem. Res. 36 (2003) 378-384
37. Pinna L.A. Casein kinase 2: an 'eminence grise' in cellular regulation?. Biochim. Biophys. Acta 1054 (1990) 267-284
38. Meggio F., Marin O., and Pinna L.A. Substrate specificity of protein kinase CK2. Cell. Mol. Biol. Res. 40 (1994) 401-409
39. McKendrick L., Milne D., and Meek D. Protein kinase CK2-dependent regulation of p53 function: evidence that the phosphorylation status of the serine 386 (CK2) site of p53 is constitutive and stable. Mol. Cell. Biochem. 191 (1999) 187-199
40. Mainou B.A., Everly Jr. D.N., and Raab-Traub N. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K. Oncogene 24 (2005) 6917-6924
41. Xie P., and Bishop G.A. Roles of TNF receptor-associated factor 3 in signaling to B lymphocytes by carboxyl-terminal activating regions 1 and 2 of the EBV-encoded oncoprotein latent membrane protein 1. J. Immunol. 173 (2004) 5546-5555